The present report is concerned primarily with the physiological disposition and fate of hydrocortisone in man. Large doses of this steroid have been administered intravenously, and the rate of its disappearance from plasma has been determined in normal subjects and in patients with liver disease and various endocrinopathies. The following procedure is a modification of the recently published method of Silber and Porter (1):
The present report is concerned primarily with the physiological disposition and fate of hydrocortisone in man. Large doses of this steroid have been administered intravenously, and the rate of its disappearance from plasma has been determined in normal subjects and in patients with liver disease and various endocrinopathies. Trace quantities of hydrocortisone-4-C14 have been employed in certain studies, either alone or as a label for the larger doses. From these studies information has been obtained regarding rates of metabolic transformation, rates and routes of excretion of hydrocortisone and its metabolites, and to some extent the identity and amounts of these metabolites. Data on the rate and extent of absorption of hydrocortisone after oral administration have also been obtained. Since, in most respects, the results obtained upon administering large or trace quantities of hydrocortisone did not differ greatly, the findings are to a considerable extent also applicable to problems of endogenous hydrocortisone metabolism.
MATERIALS AND METHODS

Administration of steroid
Fifty to 500 mg. of hydrocortisone were dissolved in ethanol and added to 500 ml. of sterile 5 per cent dextrose in water, producing a final alcohol concentration of 2 to 3 per cent. This solution was given intravenously over a period of 20 to 30 minutes. Following the infusion, blood samples were drawn in heparinized syringes every 20 to 30 minutes for 2 to 3 hours. Urine samples were collected for 24 hours or longer in single or fractional specimens, and preserved by freezing. Procedure for determination of plasma hydrocortisone
The following procedure is a modification of the recently published method of Silber and Porter (1):
Principle-Hydrocortisone is extracted from plasma into dichloromethane. The dichloromethane extract is washed with aqueous alkali to remove a considerable amount of "blank" material. The dichloromethane is then shaken with a sulfuric acid-ethanol reagent, containing phenylhydrazine. The resulting colored product is measured in the acid phase spectrophotometrically at 410 mny.
A correction for material in plasma reacting with sulfuric acid is made by treating an equal aliquot of dichloromethane extract of plasma with sulfuric acid-ethanol which contains no phenylhydrazine.
Reagents.
(a) Dichloromethane-This solvent is purified by passing through a bed of silical gel (average 100 mesh) in a 7 by 125 cm. column. Ten to twenty liters can be purified in 2 to 3 hours. The effectiveness of purification is determined by shaking an aliquot of solvent with the phenylhydrazine-sulfuric acid-ethanol reagent (f). No color should develop on standing overnight at room temperature. The solvent has remained free of impurities for many months at room temperature.
(b) 01 N Sodium Hydroxide. (c) 70 Per Cent Sulfuric Acid-700 ml. acid C.P. grade sulfuric acid added to 300 ml. H2O .
(d) Ethanol-This is purified by adding 7 gm. silver nitrate and 15 gm. potassium hydroxide, separately (each dissolved in 100 ml. ethanol) to 4 liters of absolute ethanol. These are mixed, allowed to stand overnight, and then distilled, using a Vigreaux column. The first 700 ml. and the last 100 ml. portions are discarded. The effectiveness of purification is determined by reacting this ethanol with the phenylhydrazine-sulfuric acid (f). No color should develop on standing overnight at room temperature.
(e) Blank Reagent-Two parts (c) with one part (d).
(f) Phenylhydrazine-Sulfuric Acid-Ethanol Reagent-50 mg. of phenylhydrazine hydrochloride (recrystallized from ethanol and water) are dissolved in 50 ml. of the blank reagent (e).
(g) Hydrocortisone Standard-100 mg. of hydrocortisone are dissolved in 100 ml. absolute ethanol. A working standard is made by diluting one ml. to a volume of PETERSON, WYNGAARDEN, GtJERRA, BRODIE, AND BUNIM 2. Washing-After aspirating as much plasma as possible, add 2 ml. 0.1 N sodium hydroxide to dichloromethane extract, shake for 15 to 20 seconds, and then remove the alkali layer by aspiration.
3. Aliquots-Transfer two 10-ml. aliquots (for unknown and blank) and place in separate 15-ml. ground glass stoppered conical test tubes.
4. Color Development-For unknowns, add 0.2 ml. phenylhydrazine-sulfuric acid-ethanol reagent (f) to dichloromethane extract aliquot; for blanks, add 0.2 ml. blank reagent (e). Stopper the tubes, shake vigorously for 15 to 20 seconds, and allow to stand for 30 minutes or more. The supernatant dichloromethane phase is removed by aspiration and the sulfuric acid-ethanol solution allowed to stand at room temperature for 10 or more hours for maximum color development. Specificity of procedure for determination of hydrocortisone in plasma after administration of hydrocortisone-Specificity of the method was shown by countercurrent distribution. Plasma drawn 90 minutes after the end of a 30-minute intravenous infusion of 200 mg. of hydrocortisone was extracted with dichloromethane, the extract evaporated to dryness, and the apparent hydrocortisone subjected to an eight-transfer counter-current distribution. The solvents used were water (8 volumes) and chloroform (1 volume) . This system gave a partition coefficient of about 0.1 for authentic hydrocortisone. A trace quantity of hydrocortisone4-C' was added before the counter-current distribution. After distribution, aliquots of both phases were analyzed for carbon"4 and by the phenylhydrazine procedure. Figure 1 demonstrates the distribution of the phenylhydrazine reacting material and the carbon1' hydrocortisone. These data demonstrated that more than 90 per cent of the material assayed with phenylhydrazine was distributed as hydrocortisone.
The specificity of the analytical procedure employed was further demonstrated by subjecting dichloromethane extracts of plasma obtained 60 and 120 minutes following the end of a 30-minute infusion of 200 mg. of hydrocortisone to paper chromatography, using a modification of the Bush (2) type system. A small quantity of hydrocortisone-4-C1' was added to the dichloromethane extract and the specific activity of the phenylhydrazine reacting material was determined. The extract was then chromatographed at room temperature for 6 hours in a benzene-methanol-water (4:2: 1) system. The hydrocortisone of the extract, running at the same rate as pure hydrocortisone, was located by ultraviolet scanning. This area was cut out and eluted with 3 ml. of 95 per cent ethanol, and the eluate evaporated to dryness under nitrogen. The residue was redissolved and the specific ac- Table I shows the specific activity of the material before and after chromatography. Portions of the steroid eluted from the paper were also assayed fluorometrically by a modification of the highly specific method described by Sweat (3) . Other eluted portions were treated so as to convert the hydrocortisone to its acetate which was then chromatographed, eluted, and assayed. These procedures confirmed the data obtained by counter-current distribution studies. Procedure for determination of hydrocortisone metabolites in urine-The method and reagents were the same as those described for plasma, except that to the urine (10 ml.) 2 ml. 0.5 M phosphate buffer (pH 6.2) and 1000 units Sigma bacterial glucuronidase in one ml. of water were added. Following incubation for 24 hours at 37°C., the mixture was extracted with 8 to 9 volumes of dichloromethane. After washing the dichloromethane extract with 1/20 volume 0.1 N NaOH, aliquots (40 ml.) were extracted with 3.0 ml. of the phenylhydrazine-sulfuric acid-ethanol, and the sulfuric acid-ethanol reagent as described for plasma. The resulting colored product was measured at 410 miu.
COUNTER-CURRENT
Phenylhydrazine reacting materials extracted from urine either directly or after 8- Liver function tests were compatible with a diagnosis of obstructive jaundice. Surgical exploration 1 revealed the presence of cholecystitis and chololithiasis, and in addition revealed an acute pancreatitis completely obstructing the common bile duct which was dilated to 3 to 4 times its normal size. No stones were found on exploration of the common bile duct. The sphincter of Oddi was cut. A T-tube was inserted in the common duct, and at its distal end was attached a small "Foley-type" catheter. These two tubes were led to the outside. Bile was permitted free access to the T-tube and to the duodenum through the common duct; however, the distal end of the common duct could be obstructed at will by inflating the Foley catheter bag with 1 to 2 ml. water, thereby draining all the bile through the T-tube. On the morning of the study, the bile duct was obstructed and the patient was given 1.5 *c. of hydrocortisone-4-C1' intravenously. Bile samples were collected every two hours for 12 hours, and for the following 12 hours. Feces and urine were also collected. Procedure for carbon"' analyses of samples-All analyses for carbon1' were carried out with a Robinson (4) gas-flow counter, using a gas mixture of nine parts argon and one part methane, and connected to a Nuclear Model 172 scaler. This apparatus gave a background of 3 to 4 cpm and an efficiency for carbon"' of slightly more than 53 per cent when counted at infinite thinness. Planchets of stainless steel with a surface area of 1.6 sq. cm. and a depth of 0.6 cm. were used. They were cleaned by boiling with alcoholic potassium hydroxide.
From 0.05 to 0.30 ml. of fresh urine was plated directly onto tared planchets. The urine was dried on a rotating platform with the aid of air and heat from an infrared lamp, and the planchets were then placed in a desiccator until weighed and counted. A correction for self-absorption was made from a self-absorption curve of urine, and all samples were corrected to infinite thinness. Self Figure 2 are shown the plasma levels and the biological half-times obtained in a single normal subject following the infusion of quantities of hydrocortisone ranging from 50 to 500 mg. The half-times are virtually identical, indicating that the rate of disappearance of hydrocortisone from plasma is proportional to concentration over a wide range of plasma levels. ; _ * f f * < s I -: ; -i E --- No studies were carried out on patients with hyperadrenalcorticism; however, the rate of disappearance of hydrocortisone from the plasma of a patient with rheumatoid arthritis who had been maintained on 100 mg. of hydrocortisone for 6 weeks, and of another who had been taking 75 mg. a day for more than a year, was within the normal range.
Comparative rates of disappearance from plasma of steroids structurally related to hydrocortisone - Figure 4 demonstrates the rate of disappearance from the plasma in a normal subject of six different steroids 2 structurally related to hydrocortisone, including one with physiologically similar actions (cortisone). Figure 5 demonstrates the disappearance from the plasma of the same steroids in a patient with cirrhosis of the liver. With the exception of hydrocortisone, whose disappearance was greatly delayed in the subject with liver dis- 2 The cortisone, lla-hydrocortisone, and tetrahydrocortisone were assayed by the phenylhydrazine procedure as described in the Methods section. The corticosterone, lla-corticosterone, and 20#-ol-hydrocortisone were assayed by a modification of the fluorometric method of Sweat (3) . This method involves exactly the same extraction procedure as described for the phenylhydrazine method. However, the steroid was extracted from the washed dichloromethane extract with one ml. of a reagent containing 7 parts by volume concentrated sulfuric acid and 3 parts by volume ease, the rate of disappearance of each steroid tested was not strikingly different in the normal and in the cirrhotic subject. Furthermore, all of these steroids disappeared at rates faster than hydrocortisone in both subjects. 3 Disappearance of radioactive hydrocortisone from pkasma-Following intravenous infusion of tracer quantities of hydrocortisone-4-C14, the concentration in plasma of isotopic substances extractable with dichloromethane decreased logarithmically with time ( Figure 6 ). Half-times of 60 to 90 minutes (10 subjects) were obtained. Not all the extracted material represented unaltered hydrocortisone, however, and in 3 subjects the results of chromatographic analyses of plasma exSThe method described for phenylhydrazine reacting steroids in plasma following their infusion, has been found not to be specific for cortisone (8) . Approximately 50 per cent of the material reacting with phenylhydrazine 60 minutes after termination of the infusion is not cortisone. The specificities of the methods used for the other steroids have not been determined.
,GUERRA, BRODIE, AND BUNIM tracts obtained from 40 minutes to 4 hours after infusion indicated that from 40 to 60 per cent of the radioactivity of this fraction was attributable to the presence of other products. In a given subject the fraction of unconjugated steroid that was hydrocortisone was constant over this time span, however. The identity of the other labeled products was not established, although a reasonable guess as to their nature may be made from the analyses of the freely extractable group of labeled urinary metabolites described in this paper. In addition to the unconjugated metabolites in plasma, there is present a fraction of labeled metabolites that is rendered dichloromethane soluble following ,-glucuronidase hydrolysis. Such a class of conjugated plasma corticoid constituents has previously been demonstrated, using chromatographic (9) and colorimetric (10) (11) . In the present study, the rate of appearance of labeled metabolites of hydrocortisone in conjugated form in plasma has also been followed ( Figure 6 ). As free steroid disappears from plasma, conjugated derivatives hydrolyzable with 8-glucuronidase appear, and reach a maximum at about 2 hours, at which time the free and conjugated fractions are of equal magnitude. Thereafter, the conjugated fraction greatly exceeds the free fraction of labeled steroids. Following extraction of both free and conjugated labeled products, the residual plasma was analyzed for radioactivity, and none was detected. hours at 370 C. with gentle continuous motion. To one or both phases, graded amounts of hydrocortisone, labeled with a tracer quantity of radioactive hormone, were added. At the end of the equilibration period, aliquots of both phases were extracted with dichloromethane, and the extract reduced in volume in vacuo. The concentrated extracts were then analyzed for hydrocortisone by phenylhydrazine and radioactivity assay procedures. Over the concentration range of 2 to 1,000 micrograms per 100 ml., 75 per cent of the hydrocortisone present in plasma was bound to the non-diffusible elements of plasma.
Uptake of hydrocortisone by erythrocytesThree in vitro and one in vivo experiments were performed to evaluate the extent of diffusion of hydrocortisone into the erythrocyte. Fresh heparinized whole blood drawn from one subject was incubated with a tracer quantity of labeled hydrocortisone at 250 C. and 370 C. for one and two hours, with gentle agitation. After the incubation period, aliquots of whole blood, of separated plasma, and of packed cells (hemolyzed in water) were extracted with dichloromethane, and radioactivity measurements made on the extracts. The (Figure 8 ). Two pronounced areas appeared among the polar fractions; however, paper chromatographic fractionation of the material comprising these two areas showed at least two phenylhydrazine reacting compounds in the area on the left and three in the area on the right (more polar). The two components of the area on the left migrated on paper as hydrocortisone and tetrahydrocortisone. One of the compounds in the more polar area on the right migrated as the tetrahydro derivative of hydrocortisone. One of the compounds migrated slightly faster and one slightly slower than the tetrahydro derivative of hydrocortisone. All of these substances (hydrocortisone, tetrahydrocortisone, tetrahydrohydrocortisone) gave the appropriate color reactions with phenylhydrazine and blue tetrazolium, and the anticipated absorption curves in sulfuric acid. In addition, when run as mixed chromatograms, both before and after conversion to the acetates, they behaved in the same manner as the authentic compounds.
Following the infusion of hydrocortisone into a patient with cirrhosis of the liver, the metabolites appeared in urine more slowly than in the normal subject (Figure 7) . Also, the total excretion of freely extracted steroid was greater than that found in the normal subject.
Urinary excretion of radiometabolites of hydrocortisone- Figure 9 demonstrates the cumulative urinary excretion of labeled hydrocortisone and metabolites following intravenous administration of a tracer quantity of hydrocortisone-4-Cl". Eighty per cent of the injected dose was excreted within the first 24 hours. A small additional quantity appeared during the second and third 24-hour periods, and by the fourth day no labeled urinary products could be demonstrated. In a total of five such studies, an average of more than 90 per cent of the radioactivity was accounted for through urinary excretion (Table II grams, but as yet none of these has been positively identified in our laboratory. Biliary excretion of radiometabolites of hydrocortisone-Following intravenous administration of labeled hydrocortisone to the patient with the biliary cannula, the rate of accumulation of metabolites in the urine, and the total quantity appearing, were much the same as in the normals. The total quantity of metabolites appearing in the bile, however, was only 4 per cent of the injected dose.6 Analysis of the feces collected for 3 days after infusion of the steroid failed to reveal the presence of any radioactivity.
Direct dichloromethane extraction of the bile failed to recover any radioactive products. Direct extraction of the feces in the normal subjects demonstrated that none of the labeled substances was in the free form.
Absorption of hydrocortisone
Absorption of orally and intramuscularly administered hydrocortisone-With the oral administration of 200 mg. of hydrocortisone to fasting normal subjects, peak plasma levels were obtained in 1 to 2 hours (Table III) , indicating rapid absorption of the hormone. The peak plasma steroid concentrations were of the same order of magnitude as the extrapolated initial concentrations obtained following intravenous administration of 200 mg. (Figure 2 ). The plasma concentration had returned to normal levels within 8 to 12 hours.
Following intramuscular administration of hydrocortisone, peak levels were reached more slowly than following oral administration, and were not nearly as high; however, the concentrations remained elevated for a slightly longer period of time (Table III) .
Following oral administration, as with intravenous infusion of hydrocortisone, 20 to 30 per cent of the administered steroid was recovered in the urine as phenylhydrazine reacting metabolites of hydrocortisone. After intramuscular injection an equivalent quantity was recovered; however, it appeared in the urine at a slower rate. The rate of disappearance of hydrocortisone from plasma has the characteristics of a first order reaction. Since less than 1 per cent of administered hydrocortisone was excreted as unaltered hormone, the rate of disappearance of hydrocortisone from plasma is presumably also a measure of the rate of its metabolism. In most cirrhotic patients studied, hydrocortisone was the only steroid for which a striking defect in rate of metabolism was demonstrable. Tomkins and Isselbacher (13, 14) have described a specific triphosphopyridine nucleotide-linked enzyme present in rat liver catalyzing the reduction of the A4 bond of hydrocortisone, but without effect on the M4 bond of other steroids. The product of hydrocortisone reduction is dihydrohydrocortisone, which is then further reduced by a second less specific enzyme (3-hydroxysteroid. dehydrogenase [14] ) to tetrahydrohydrocortisone. The first reaction is rate controlling, so that the intermediate product does not normally accumulate. Moreover, the dihydro-derivatives do not appear in urine of man to any significant extent (15) . These findings suggest that the rate-controlling step in the removal of hydrocortisone from plasma may be the reduction of the A ring of the hormone in the liver, and that it is the enzyme catalyzing this transformation that is deficient in hepatic diseases of the types studied. A finding consistent with this thesis is the observation that tetrahydrocortisone disappears from plasma at a normal rate in patients with liver disease (12) (Figure 5) .
The ameliorating effects of jaundice (16) upon active rheumatoid arthritis may well be related to a defect in biological transformation of endogenous hydrocortisone resulting from liver dysfunction. The rate of disappearance of hydrocortisone was clearly delayed in only one of eight rheumatoid arthritics studied.
In two of three patients with thyrotoxicosis, the rate of disappearance of infused hydrocortisone was increased. In two of three with myxedema, hydrocortisone disappearance was delayed. Since similar disturbances were noted after infusion of cortisone, these alterations presumably result from general disturbances of rates of metabolic processes associated with alterations of thyroid function.
In adrenal insufficiency, both primary and secondary, the rates of disappearance of hydrocortisone were normal. Also, in patients who had previously received large doses of hydrocortisone for long periods, the disappearance of infused hydrocortisone was normal. Hellman, Bradlow, Adesman, Fukushima, Kulp, and Gallagher (17) (Figure 2 ), considered together with the quantity of hydrocortisone injected, an apparent volume of distribution of 50 to 90 liters can be calculated.7 (Average = 70 liters 8 in 20 normal and 12 cirrhotic subjects given 50 to 500 mg. of hydrocortisone intravenously.)
In the strictest sense these calculations mean that at the moment of complete mixing it would take a volume of 70 liters to contain all the injected hydrocortisone in the concentration at which it exists in plasma. Since the figures obtained are in all cases close to total body weight, it follows that hydrocortisone is concentrated in some portions of the body at much higher levels than are present in plasma. Tissue localization has been demonstrated to occur in the red cell and in the non-diffusible elements of plasma, and probably occurs in other tissues as well.
When the hydrocortisone space is calculated from the value for the miscible pool as determined by conventional treatment of serial specific activity values of circulating hydrocortisone (18) , and the plasma level of phenylhydrazine reacting steroid (largely hydrocortisone [11] ), hydrocortisone spaces of 8 to 16 liters (12 subjects) are obtained. The method for determination of the miscible pool depends upon knowledge of the initial concentration of isotopic hydrocortisone in plasma. The addition of new unlabeled hormone will dilute the pool and change its isotope concentration; the removal of hormone from the pool will not. Therefore, only that hydrocortisone capable of mixing with circulating hydrocortisone will be determined by this method.
The discrepancy between values obtained by these two methods is at least in part attributable to the fact that in the estimation of a volume of distribution, equilibration of solute is assumed 7 Similar calculations made on the basis of the extrapolated value for the concentration of dichloromethane extractable radioactive substances present in plasma at zero time, after infusion of tracer quantities of hydrocortisone-4-C'4 can have no significance, since it has been shown that a large fraction of these substances is not hydrocortisone.
8This figure of 70 liters is based on the concentrations of free plus plasma protein bound steroid. By employing the free steroid concentration for the calculation, an apparent volume of 280 liters is obtained.
to have occurred prior to any irreversible transformation or excretion of the test substance. This assumption cannot be valid in the case of hydrocortisone which is known to be metabolized rapidly. The hydrocortisone which is enitering such irreversible fates undoubtedly makes a larger contribution to the volume of distribution when measured from hydrocortisone disappearance data than when measured from the isotope dilution data. The value arrived at from isotope dilution data, 8 to 16 liters, is perhaps a fairly accurate indication of the volume of water required to contain the miscible hydrocortisone at the concenitration at which it occurs in plasma.
Excretory pathways of wietabolites of hydrocortisone The major route of excretion of labeled metabolites of hydrocortisone was via the urine, in which 86 to 94 per cent of the administered carbon14 appeared in 72 hours. These figures are in good agreement with those of Hellman and his associates (17) and Plager, Tyler, Hecht, and Samuels (19) . Less than one per cent of the administered hormone was excreted as free hydrocortisone. These data suggest that no accumulation of hydrocortisone within the body would result from renal failure such as might be anticipated from hepatic failure.
Only a minor fraction, about 3 per cent, of the administered isotope was recovered in feces. This value is somew-hat lower than those reported by Hellman (17) and by Plager and their coworkers (19) . The quantity of labeled products appearing in feces was only slightly less than that excreted in bile, suggesting that the bile is the major and perhaps the sole source of fecal products. Furthermore, it appears unlikely that appreciable intestinal reabsorption of biliary metabolites of hydrocortisone occurs. These data are in striking contrast with those obtained in rats and guinea pigs in which 60 to 80 per cent of the administered hydrocortisone-4-C14 appeared in biliary metabolites, much of it destined subsequently to participate in an active entero-hepatic circulation in both species (20) . These findings are also different from those obtained with progesterone-4-C14 in man, where 60 per cent of the radiometabolites appeared in bile (21 (23, 24) , and react wN-ith phenylhydrazine. Small additional quantities are detectable as 17-ketosteroids, but the sum of all classes of urinary metabolites recognizable by these various methods is less than 40 per cent of the administered dose.
In the present study, recoveries of metabolites in urine, as determined by the phenylhydrazine method after glucuronide hydrolysis agreed well with these earlier reports. However, both in the freely extractable and the glucuronidase hydrolyzed fractions, the percentage of the administered hormone detected by radioactivity analysis was considerably larger than that determined by colorimetric assay. (26) have shown that in gastric juice (pH 1.0) and bile (pH 7.0) no transformation takes place for at least 36 hours (370 C.). In feces, however, after 4 hours all hydrocortisone had been metabolized.
SUMMARY
The physiological disposition and metabolic fate of hydrocortisone have been studied in man following intravenous infusion of hormone in doses up to 500 mg. In normal subjects the halflife of infused hydrocortisone in plasma averaged 1.9 hours. Following the infusion of tracer quantities of hydrocortisone-4-C14, labeled conjugated metabolites appeared in plasma, and at 2 hours their concentration was equal to that of labeled unconjugated substances. Normal subjects excreted over 90 per cent of the administered hormone as urinary metabolites in 72 hours, as judged from excretion of carbon14 following infusion of tracer or labeled larger quantities of hormone. Feces of three normal subjects contained 2 to 4 per cent of the administered label, and in one sub-100-C4 HYDROCORTISONE 1. V. ject with a biliary catheter, 4 per cent of the infused label appeared in the bile. About 4 per cent of the administered hormone was excreted in urine as unconjugated substances; unchanged hydrocortisone represented less than 1 per cent of the administered hormone. The routes of hydrocortisone disposition in man are schematically illustrated in Figure 12 . About 60 per cent of the administered hydrocortisone was excreted as metabolites hydrolyzable with bacterial f8-glucuronidase, although only about half of this fraction was (letectable by the phenylhydrazine reaction.
In patients with liver disease disappearance of infused hydrocortisone was slower than normal.
There was an associated increase in the fraction of infused hormone excreted in unconjugated form, and also a slower appearance of conjugated metabolites in urine. The defect in metabolism of hydrocortisone in patients with liver disease was discussed in terms of a low hepatic activity of the specific enzyme catalyzing the reduction of the A4 bond of hydrocortisone. from plasma were increased in two of three patients with moderately severe thyrotoxicosis. and slowed in two of three with imyxedema. Disappearance rates were normal in three subjects with hypoadrenalcorticisimi.
The absorption of tracer quantities of hydrocortisone from the gastrointestinal tract wvas shown to be rapid and comiiplete. No destruction of hydrocortisone was detected after incubation of labeled hormone with gastric juice, bile, or serum, but extensive destruiction occturred (luring inctubation with feces.
